The ESC Clinical Consensus Statement on Obesity and Cardiovascular Disease, presented at this year’s ESC Congress (London, UK, 30 August to 2 September) summarizes current evidence on the epidemiology and etiology of obesity; the interplay between obesity, cardiovascular risk factors and cardiac conditions; the clinical management of patients with cardiac disease and obesity; and weight loss strategies including lifestyle changes, interventional procedures, and anti-obesity medications with particular focus on their impact on cardiometabolic risk and cardiac outcomes.
Sanofi enters partnership to enhance drug development using AI
Sanofi will offer its extensive data under the deal to develop solutions for drug development. Credit: HJBC / Shutterstock.com. Sanofi has collaborated with Formation Bio